Silymarin shows mild antiosteoporotic effectsEvidences for antiosteoporotic and selective estrogen receptor modulator activity of silymarin compared with ethinylestradiol in ovariectomized rats.
We explored how silymarin (SIL) could work as an alternative treatment for osteoporosis in ovariectomized (OVX) rats. During a 12-week study, we compared its effects with those of ethinylestradiol (EE).
Both SIL and EE helped protect bone density, but SIL had milder effects on the uterus and did not significantly lower levels of certain bone markers like osteocalcin.
While SIL showed promise in promoting bone health, its overall impact was not as strong as that of EE, suggesting a need for further research in humans.
Read More
Effect of ZnO-NPs on osteoporosisFoliar spraying with zinc oxide nanoparticles enhances the anti-osteoporotic efficacy of the fruit extracts of L. by stimulating silybin production.
We investigated the impact of foliar spraying with zinc oxide nanoparticles (ZnO-NPs) on a specific plant known for its silymarin content.
By applying these nanoparticles, we saw an increase in the beneficial compounds silybin (A+B), enhancing the plant’s growth and medicinal properties. This method also positively influenced the plants' ability to combat osteoporosis.
In tests, extracts from these treated plants showed potential to improve bone health in rats suffering from osteoporosis, including stimulating bone formation and reducing bone resorption.
Read More
Silymarin shows potential for osteoporosisMilk thistle: a future potential anti-osteoporotic and fracture healing agent.
We examined how silymarin, the key compound found in milk thistle, might help treat osteoporosis. This review highlights its potent antioxidant properties and potential to enhance bone formation, particularly in postmenopausal women who are at higher risk for fractures.
Our findings suggest that silymarin may improve bone health by increasing bone density and encouraging healing after fractures in models. While promising, silymarin’s effectiveness and any potential side effects need further investigation before becoming a recommended treatment.
Read More
Milk thistle extract shows promiseAntiosteoclastic activity of milk thistle extract after ovariectomy to suppress estrogen deficiency-induced osteoporosis.
We investigated how milk thistle extract (MTE), rich in silymarin, impacts osteoporosis in mice after ovariectomy, simulating postmenopausal conditions.
Over eight weeks, we observed that MTE and its key component, silibinin, positively influenced bone density and reduced bone loss associated with estrogen deficiency.
Our findings suggest MTE can enhance bone formation and limit bone resorption, comparable to traditional estrogen treatments. This positions MTE as a promising option for addressing bone health in postmenopausal individuals.
Read More
Promising silibinin effects on osteoporosisOsteoblastogenesis and osteoprotection enhanced by flavonolignan silibinin in osteoblasts and osteoclasts.
In our exploration, we found that silibinin, a key component of silymarin derived from milk thistle, shows promising effects on osteoporosis treatment. Through in vitro studies involving murine osteoblast and macrophage cells, silibinin not only boosted bone formation by promoting the growth and mineralization of bone cells but also helped inhibit the harmful activity of osteoclasts, which are responsible for bone resorption.
Although these findings are encouraging, it’s essential to note that further research is needed to confirm its efficacy and potential for use in clinical settings.
Read More